跳转至内容
Merck
  • Influence of copolymer composition on the phase behavior of solid dispersions.

Influence of copolymer composition on the phase behavior of solid dispersions.

Molecular pharmaceutics (2014-10-09)
Anke Prudic, Tobias Kleetz, Marcel Korf, Yuanhui Ji, Gabriele Sadowski
摘要

The incorporation of poorly soluble active pharmaceutical ingredients (APIs) into excipients (e.g., polymers) to formulate an amorphous solid dispersion is a promising strategy to improve the oral bioavailability of the API. The application of copolymer excipients allows access to combinations of different monomers and thus to the design of excipients to improve solid-dispersion properties. In this work, the thermodynamic phase behavior of solid dispersions was investigated as a function of the API, type of monomer, and copolymer composition. The glass-transition temperatures and API solubilities in the solid dispersions of naproxen and indomethacin in polyvinylpyrrolidone, polyvinyl acetate, and copolymers with different weight fractions of vinylpyrrolidone and vinyl actetate were investigated. It is shown that the thermodynamic phase behavior of API/copolymer solid dispersions is a function of monomer type and copolymer composition. This effect was also predicted by using the perturbed-chain statistical associating fluid theory (PC-SAFT). The glass-transition temperature of the solid dispersions was calculated with the Gordon-Taylor equation.

材料
货号
品牌
产品描述

Sigma-Aldrich
吲哚美辛, 98.5-100.5% (in accordance with EP)
Supelco
萘普生, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
吲哚美辛, meets USP testing specifications
USP
萘普生, United States Pharmacopeia (USP) Reference Standard
Supelco
吲哚美辛, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
(S)-(+)-6-甲氧基-α-甲基-2-萘乙酸, 98%
Sigma-Aldrich
萘普生, meets USP testing specifications
USP
吲哚美辛, United States Pharmacopeia (USP) Reference Standard
萘普生, European Pharmacopoeia (EP) Reference Standard
Supelco
氧萘丙酸, VETRANAL®, analytical standard
吲哚美辛, European Pharmacopoeia (EP) Reference Standard